Events

Webinar: Recent Trends on Patents for Antibody Drugs in Japan

As Optivo, the world renowned anti-cancer drug, was developed by Tasuku Honjyo, the Nobel laureate, in 2017, R&D on antibody drugs has come to draw more attention than ever. In light of Japanese patent practice, pharmaceutical companies and research institutes face new challenges on the scope of patent protection when filing applications related to antibody drug patents. In his presentation, Dr. Iida will provide a brief outline of the patent practice related to antibody drugs and how you can prepare your specification to cover a broad scope of protection in Japan.

We are committed to accessibility! Virtual events are equipped with closed captioning. To request an in-person accommodation, send us a note at accessibility@calawyers.com or contact us at 916-516-1760 for assistance.

 

View all CLA events

Forgot Password

Enter the email associated with you account. You will then receive a link in your inbox to reset your password.

Personal Information

Select Section(s)

CLA Membership is $99 and includes one section. Additional sections are $99 each.

Payment